News

Tuesday September 24, 2019

24 Sep 2019 – Destiny Pharma Interim results presentation and audio recording

Please find links to the Destiny Pharma Interim results presentation and audio recording held on 23rd September 2019:- Interim results 2019 presentation Audio recording (MP3)

Monday September 23, 2019

23 Sep 2019 – Directorate change

Destiny Pharma plc (“Destiny Pharma” or “the Company”) Directorate change Brighton, United Kingdom – 23 September 2019 – Destiny Pharma (AIM: DEST), a clinical stage biotechnology company focused on the […]

Monday September 23, 2019

23 Sep 2019 – Interim results for the 6 months ended 30 June 2019

Destiny Pharma today announced its interim results for the 6 months ended 30 June 2019, which can be found here.

Wednesday September 11, 2019

11 Sep 2019 – Public Health England announced its new strategy to address AMR

Tuesday September 10, 2019

10 Sep 2019 – Destiny Pharma awarded grant to fund a research collaboration with t...

Monday September 2, 2019

02 Sept 2019 – Destiny Pharma XF Drug platform data to be presented at EuroBiofilm...